These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25249497)

  • 1. Implantable cardioverter-defibrillators in children.
    DeWitt ES; Abrams DJ
    Arch Dis Child; 2015 Mar; 100(3):265-70. PubMed ID: 25249497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in the treatment of arrhythmias: implantable cardioverter-defibrillators.
    Groh WJ; Foreman LD; Zipes DP
    Am Fam Physician; 1998 Jan; 57(2):297-307, 310-2. PubMed ID: 9456993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantable cardioverter defibrillators in children.
    Chun TU; Collins KK; Dubin AM
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):561-71. PubMed ID: 15225115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in the use of implantable cardioverter defibrillators in Australia: a 10-year nationwide study from 2000-2009.
    Burch AW; Wong CX; Sullivan T; Brooks AG; Leong DP; Lau DH; Sun MT; Roberts-Thomson KC; Sanders P
    Intern Med J; 2013 Aug; 43(8):888-95. PubMed ID: 23734916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the main implantable cardioverter-defibrillator trials in clinical practice: data from the Italian ICD Registry for the years 2005-07.
    Proclemer A; Ghidina M; Gregori D; Facchin D; Rebellato L; Fioretti P; Brignole M
    Europace; 2009 Apr; 11(4):465-75. PubMed ID: 19136490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator.
    Korte T; Köditz H; Niehaus M; Paul T; Tebbenjohanns J
    Pacing Clin Electrophysiol; 2004 Jul; 27(7):924-32. PubMed ID: 15271011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implantable cardioverter defibrillators: risks accompany the life-saving benefits.
    Atwater BD; Daubert JP
    Heart; 2012 May; 98(10):764-72. PubMed ID: 22422588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.
    Klein HU; Goldenberg I; Moss AJ
    Eur Heart J; 2013 Aug; 34(29):2230-42. PubMed ID: 23729691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of implantable cardioverter-defibrillators in patients with continuous flow left ventricular assist devices.
    Enriquez AD; Calenda B; Miller MA; Anyanwu AC; Pinney SP
    Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):668-74. PubMed ID: 23873139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electromagnetic interference with implantable cardioverter-defibrillators at power frequency: an in vivo study.
    Napp A; Joosten S; Stunder D; Knackstedt C; Zink M; Bellmann B; Marx N; Schauerte P; Silny J
    Circulation; 2014 Jan; 129(4):441-50. PubMed ID: 24163067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [14-year experience with implantable cardioverter/defibrillators: determination of prognosis and discharge behavior].
    Vester EG; Dees H; Dobran I; Hennersdorf M; Perings C; Heydthausen M; Winter J; Strauer BE
    Z Kardiol; 2000; 89 Suppl 3():194-205. PubMed ID: 10810803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential impact of antiarrhythmic drugs versus implantable defibrillators on the management of ventricular arrhythmias: the Midlands trial of empirical amiodarone versus electrophysiologically guided intervention and cardioverter implant registry data.
    Pathmanathan RK; Lau EW; Cooper J; Newton L; Skehan JD; Garratt CJ; Griffith MJ
    Heart; 1998 Jul; 80(1):68-70. PubMed ID: 9764063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indications for implantable cardioverter defibrillator (ICD) therapy. Study Group on Guidelines on ICDs of the Working Group on Arrhythmias and the Working Group on Cardiac Pacing of the European Society of Cardiology.
    Hauer RN; Aliot E; Block M; Capucci A; Lüderitz B; Santini M; Vardas PE;
    Eur Heart J; 2001 Jul; 22(13):1074-81. PubMed ID: 11428848
    [No Abstract]   [Full Text] [Related]  

  • 14. Implantable cardioverter defibrillators.
    Shah CP; Thakur RK; Xie B; Hoon VK
    Emerg Med Clin North Am; 1998 May; 16(2):463-89. PubMed ID: 9621852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychological aspects of cardiac devices and recalls in patients with implantable cardioverter defibrillators.
    Sears SF; Conti JB
    Am J Cardiol; 2006 Aug; 98(4):565-7. PubMed ID: 16893718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of antiarrhythmic drugs in patients with implantable cardioverter defibrillators.
    Van Herendael H; Pinter A; Ahmad K; Korley V; Mangat I; Dorian P
    Europace; 2010 May; 12(5):618-25. PubMed ID: 20304841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy with implantable cardioverter-defibrillators (ICD) in the early of third millenium].
    Kozák M
    Vnitr Lek; 2010 Aug; 56(8):860-4. PubMed ID: 20845619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sudden cardiac death and implantable cardioverter defibrillators: two modern epidemics?
    Katritsis DG; Josephson ME
    Europace; 2012 Jun; 14(6):787-94. PubMed ID: 22308081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Midterm experience with implantable cardioverter-defibrillators in children and young adults.
    Çeliker A; Olgun H; Karagoz T; Özer S; Özkutlu S; Alehan D
    Europace; 2010 Dec; 12(12):1732-8. PubMed ID: 20852288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life and psychological status of patients with implantable cardioverter defibrillators.
    Thomas SA; Friedmann E; Kao CW; Inguito P; Metcalf M; Kelley FJ; Gottlieb SS
    Am J Crit Care; 2006 Jul; 15(4):389-98. PubMed ID: 16823016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.